There Should Be a Price to Pay for Knowingly Lying to Consumers
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.
Fishlock et al. v. Global Plasma Solutions, Inc.
22-cv-1566, D. Del.
(Dec. 2022)
Global Plasma Solutions products with needlepoint bipolar ionization technology
Falsely representing that products eliminate the COVID-19 virus and produce cleaner air
Deceptively representing that claims are based on “independent testing” when the testing was funded by the company
Pending
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.
Letters alert agencies and organizations to company’s improper marketing.
TINA.org discovers some roadblocks to unlocking this purportedly free offer.
New research points to “no.”
Why disclosures are key to protecting informed consumer choice and competition.